International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients

Purpose: Alpha-1 blockers, often used to treat benign prostatic hyperplasia (BPH), have been hypothesized to prevent COVID-19 complications by minimising cytokine storm release. The proposed treatment based on this hypothesis currently lacks support from reliable real-world evidence, however. We lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Akihiko, Xie, Junqing, Kostka, Kristin, Duarte-Salles, Talita, Fernández Bertolín, Sergio, Aragón, María, Blacketer, Clair, Shoaibi, Azza, DuVall, Scott L., Lynch, Kristine, Matheny, Michael E., Falconer, Thomas, Morales, Daniel R., Conover, Mitchell M., Chan You, Seng, Pratt, Nicole, Weaver, James, Sena, Anthony G., Schuemie, Martijn J., Reps, Jenna, Reich, Christian, Rijnbeek, Peter R., Ryan, Patrick B., Hripcsak, George, Prieto-Alhambra, Daniel, Suchard, Marc A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518954/
https://www.ncbi.nlm.nih.gov/pubmed/36188566
http://dx.doi.org/10.3389/fphar.2022.945592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518954/
https://www.ncbi.nlm.nih.gov/pubmed/36188566
http://dx.doi.org/10.3389/fphar.2022.945592

Ejemplares similares